Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Drug Addiction: later-stage trial registry
2 of 15 indexed Drug Addiction trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 2 currently recruiting · #1,140 of 28,707 conditions by registered trial count
Drug Addiction: 15 US clinical trials tracked, 2 recruiting.
Drug Addiction is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is T. John Winhusen, PhD, running 3 of these trials.
Enrollment posture brief
Registry condition drug-addiction
OPEN 2 | RECR 13% | LATE 3 | EARLY 1 | RANK #1140 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Hereditary Angioedema (13% recruiting · 15 trials)
Drug Addiction lists 2 open slots (13% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Drug Addiction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Drug Addiction is recruiting below its size-band peers.
2 of 15 indexed trials (13.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Drug Addiction research.
T. John Winhusen, PhD accounts for 3 of 15 trials (20%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Drug Addiction trials plan to enrol fewer than 100 people.
Median target enrolment is 89 among the 14 trials that report a genuine target (sentinel values excluded). 9 of those (64.3%) plan for fewer than 100 participants.
-
Drug Addiction splits between interventional and observational designs.
10 interventional and 5 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
Long-Term Treatment of Opioid Use Disorder
Northern Michigan University
NCT05534815
Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
National Institute on Drug Abuse (NIDA)
NCT03745339
Innovative Digital Therapeutic for Smoking Cessation
My Digital Study
NCT03694327
Treating the Partners of Drug Using Pregnant Women: Stage II
Johns Hopkins University
NCT00496990
Medication Treatment for Opioid Use Disorder in Expectant Mothers
T. John Winhusen, PhD
NCT03918850
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
T. John Winhusen, PhD
NCT03911466
Individual Differences in Reward and Impulse Control
National Institute on Drug Abuse (NIDA)
NCT01621607
Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3
Virginia Commonwealth University
NCT00390559
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
T. John Winhusen, PhD
NCT03911739
Effects of MDMA on Social and Emotional Processing
University of Chicago
NCT01849419
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
Yale University
NCT00798538
Buprenorphine and Integrated HIV Care
Yale University
NCT00317460
Cannabidiol and Emotional Stimuli
University of Chicago
NCT02902081
AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
University of Cincinnati
NCT03402672
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
National Cancer Institute (NCI)
NCT00491335
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Drug Addiction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Drug Addiction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Drug Addiction page
15 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Drug Addiction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- T. John Winhusen, PhD sponsors the most Drug Addiction trials on record, review their full trial history before evaluating a specific study. See T. John Winhusen, PhD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Drug Addiction condition card totals 15 registered trials; most-linked intervention Buprenorphine Sublingual Product; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.